| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |